Morikawa K, Arima Y, Nagakura T, Xu Y, et al. Nonsteroidal mineralocorticoid receptor antagonist finerenone ameliorates cardiac hypertrophy with increasing glucocorticoid signaling sensitivity. Biochem Biophys Res Commun 2026;802:153332.
PMID: 41579728